{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:19:03Z","timestamp":1790745543398,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,12,15]],"date-time":"2009-12-15T00:00:00Z","timestamp":1260835200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1038\/sj.bjc.6605490","type":"journal-article","created":{"date-parts":[[2009,12,15]],"date-time":"2009-12-15T21:27:43Z","timestamp":1260912463000},"page":"457-461","source":"Crossref","is-referenced-by-count":72,"title":["Epidermal growth factor signalling and bone metastasis"],"prefix":"10.1038","volume":"102","author":[{"given":"X","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,12,15]]},"reference":[{"key":"BF6605490_CR1","unstructured":"Albain K, Elledge R, Gradishar WJ, Hayes DF, Rowinsky E, Hudis C, Pusztai L, Tripathy D, Modi S, Rubi S (2002) Open-Label, Phase II, Multicenter Trial of ZD1839 (\u2018Iressa\u2019) in Patients with Advanced Breast Cancer. Breast Cancer Res Treat 76: S33 (abstract 20)"},{"key":"BF6605490_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1677\/erc.1.01100","volume":"13","author":"A Angelucci","year":"2006","unstructured":"Angelucci A, Gravina GL, Rucci N, Millimaggi D, Festuccia C, Muzi P, Teti A, Vicentini C, Bologna M (2006) Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice. Endocr Relat Cancer 13: 197\u2013210","journal-title":"Endocr Relat Cancer"},{"key":"BF6605490_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423: 337\u2013342","journal-title":"Nature"},{"key":"BF6605490_CR4","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1038\/sj.onc.1203520","volume":"19","author":"R Brandt","year":"2000","unstructured":"Brandt R, Eisenbrandt R, Leenders F, Zschiesche W, Binas B, Juergensen C, Theuring F (2000) Mammary gland specific hEGF receptor transgene expression induces neoplasia and inhibits differentiation. Oncogene 19: 2129\u20132137","journal-title":"Oncogene"},{"key":"BF6605490_CR5","doi-asserted-by":"publisher","first-page":"38693","DOI":"10.1074\/jbc.M004189200","volume":"275","author":"S-Y Chan","year":"2000","unstructured":"Chan S-Y, Wong RW-C (2000) Expression of epidermal growth factor in transgenic mice causes growth retardation. J Biol Chem 275: 38693\u201338698","journal-title":"J Biol Chem"},{"key":"BF6605490_CR6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nrm1962","volume":"7","author":"A Citri","year":"2006","unstructured":"Citri A, Yarden Y (2006) EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol 7: 505\u2013516","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BF6605490_CR7","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/jcp.21260","volume":"214","author":"A De Luca","year":"2008","unstructured":"De Luca A, Carotenuto A, Rachiglio A, Gallo M, Maiello MR, Aldinucci D, Pinto A, Normanno N (2008) The role of the EGFR signaling in tumor microenvironment. J Cell Physiol 214: 559\u2013567","journal-title":"J Cell Physiol"},{"key":"BF6605490_CR8","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1101\/gad.1854909","volume":"23","author":"TA Guise","year":"2009","unstructured":"Guise TA (2009) Breaking down bone: new insight into site-specific mechanisms of breast cancer osteolysis mediated by metalloproteinases. Genes Dev 23: 2117\u20132123","journal-title":"Genes Dev"},{"key":"BF6605490_CR9","doi-asserted-by":"publisher","first-page":"10578","DOI":"10.1073\/pnas.89.22.10578","volume":"89","author":"CT Guy","year":"1992","unstructured":"Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ (1992) Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA 89: 10578\u201310582","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6605490_CR10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nature01660","volume":"423","author":"S-i Harada","year":"2003","unstructured":"Harada S-i, Rodan GA (2003) Control of osteoblast function and regulation of bone mass. Nature 423: 349\u2013355","journal-title":"Nature"},{"key":"BF6605490_CR11","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/cncr.21778","volume":"106","author":"KR Hess","year":"2006","unstructured":"Hess KR, Varadhachary GR, Taylor SH, Wei W, Raber MN, Lenzi R, Abbruzzese JL (2006) Metastatic patterns in adenocarcinoma. Cancer 106: 1624\u20131633","journal-title":"Cancer"},{"key":"BF6605490_CR12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrc1609","volume":"5","author":"NE Hynes","year":"2005","unstructured":"Hynes NE, Lane HA (2005) ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 5: 341\u2013354","journal-title":"Nat Rev Cancer"},{"key":"BF6605490_CR13","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1073\/pnas.83.7.2228","volume":"83","author":"KJ Ibbotson","year":"1986","unstructured":"Ibbotson KJ, Harrod J, Gowen M, D\u2019Souza S, Smith DD, Winkler ME, Derynck R, Mundy GR (1986) Human recombinant transforming growth factor alpha stimulates bone resorption and inhibits formation in vitro. Proc Natl Acad Sci 83: 2228\u20132232","journal-title":"Proc Natl Acad Sci"},{"key":"BF6605490_CR14","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.2174\/092986706779026174","volume":"13","author":"JB Johnston","year":"2006","unstructured":"Johnston JB, Navaratnam S, Pitz MW, Maniate JM, Wiechec E, Baust H, Gingerich J, Skliris GP, Murphy LC, Los M (2006) Targeting the EGFR pathway for cancer therapy. Curr Med Chem 13: 3483\u20133492","journal-title":"Curr Med Chem"},{"key":"BF6605490_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0014-4827(02)00098-8","volume":"284","author":"RN Jorissen","year":"2003","unstructured":"Jorissen RN, Walker F, Pouliot N, Garrett TPJ, Ward CW, Burgess AW (2003) Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 284: 31\u201353","journal-title":"Exp Cell Res"},{"key":"BF6605490_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1053\/gast.2001.25478","volume":"121","author":"LT Kelly","year":"2001","unstructured":"Kelly LT, Noreen CL, Marian LS, Ting Hu Q, Cory JX, David CL (2001) Growth retardation, duodenal lesions, and aberrant ileum architecture in triple null mice lacking EGF, amphiregulin, and TGF-\u03b1. Gastroenterology 121: 68\u201378","journal-title":"Gastroenterology"},{"key":"BF6605490_CR17","doi-asserted-by":"publisher","first-page":"6657","DOI":"10.1038\/sj.onc.1208790","volume":"24","author":"P Khalili","year":"2005","unstructured":"Khalili P, Arakelian A, Chen G, Singh G, Rabbani SA (2005) Effect of Herceptin on the development and progression of skeletal metastases in a xenograft model of human breast cancer. Oncogene 24: 6657\u20136666","journal-title":"Oncogene"},{"key":"BF6605490_CR18","first-page":"1200","volume":"9","author":"SJ Kim","year":"2003","unstructured":"Kim SJ, Uehara H, Karashima T, Shepherd DL, Killion JJ, Fidler IJ (2003) Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice. Clin Cancer Res 9: 1200\u20131210","journal-title":"Clin Cancer Res"},{"key":"BF6605490_CR19","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1172\/JCI112517","volume":"77","author":"JA Lorenzo","year":"1986","unstructured":"Lorenzo JA, Quinton J, Sousa S, Raisz LG (1986) Effects of DNA and prostaglandin synthesis inhibitors on the stimulation of bone resorption by epidermal growth factor in fetal rat long-bone cultures. J Clin Invest 77: 1897\u20131902","journal-title":"J Clin Invest"},{"key":"BF6605490_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10911-007-9047-3","volume":"12","author":"X Lu","year":"2007","unstructured":"Lu X, Kang Y (2007) Organotropism of breast cancer metastasis. J Mammary Gland Biol Neoplasia 12: 153\u2013162","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"BF6605490_CR21","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1101\/gad.1824809","volume":"23","author":"X Lu","year":"2009","unstructured":"Lu X, Wang Q, Hu G, Van Poznak C, Fleisher M, Reiss M, Massagu\u00e9 J, Kang Y (2009) ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev 23: 1882\u20131894","journal-title":"Genes Dev"},{"key":"BF6605490_CR22","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/0092-8674(90)90077-R","volume":"61","author":"Y Matsui","year":"1990","unstructured":"Matsui Y, Halter SA, Holt JT, Hogan BLM, Coffey RJ (1990) Development of mammary hyperplasia and neoplasia in MMTV-TGF\u03b1 transgenic mice. Cell 61: 1147\u20131155","journal-title":"Cell"},{"key":"BF6605490_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0092-8674(88)90184-5","volume":"54","author":"WJ Muller","year":"1988","unstructured":"Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P (1988) Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54: 105\u2013115","journal-title":"Cell"},{"key":"BF6605490_CR24","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nrc867","volume":"2","author":"GR Mundy","year":"2002","unstructured":"Mundy GR (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2: 584\u2013593","journal-title":"Nat Rev Cancer"},{"key":"BF6605490_CR25","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1677\/erc.1.00956","volume":"12","author":"N Normanno","year":"2005","unstructured":"Normanno N, De Luca A, Aldinucci D, Maiello MR, Mancino M, D\u2019Antonio A, De Filippi R, Pinto A (2005) Gefitinib inhibits the ability of human bone marrow stromal cells to induce osteoclast differentiation: implications for the pathogenesis and treatment of bone metastasis. Endocr Relat Cancer 12: 471\u2013482","journal-title":"Endocr Relat Cancer"},{"key":"BF6605490_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.gene.2005.10.018","volume":"366","author":"N Normanno","year":"2006","unstructured":"Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, Carotenuto A, De Feo G, Caponigro F, Salomon DS (2006) Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366: 2\u201316","journal-title":"Gene"},{"key":"BF6605490_CR27","first-page":"3059","volume":"51","author":"GJ Powell","year":"1991","unstructured":"Powell GJ, Southby J, Danks JA, Stillwell RG, Hayman JA, Henderson MA, Bennett RC, Martin TJ (1991) Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res 51: 3059\u20133061","journal-title":"Cancer Res"},{"key":"BF6605490_CR28","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1074\/jbc.M409807200","volume":"280","author":"L Qin","year":"2005","unstructured":"Qin L, Tamasi J, Raggatt L, Li X, Feyen JHM, Lee DC, DiCicco-Bloom E, Partridge NC (2005) Amphiregulin is a novel growth factor involved in normal bone development and in the cellular response to parathyroid hormone stimulation. J Biol Chem 280: 3974\u20133981","journal-title":"J Biol Chem"},{"key":"BF6605490_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0378-1119(94)00866-Q","volume":"159","author":"PM Ravdin","year":"1995","unstructured":"Ravdin PM, Chamness GC (1995) The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers \u2013 a review. Gene 159: 19\u201327","journal-title":"Gene"},{"key":"BF6605490_CR30","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1056\/NEJMra030831","volume":"350","author":"GD Roodman","year":"2004","unstructured":"Roodman GD (2004) Mechanisms of bone metastasis. N Engl J Med 350: 1655\u20131664","journal-title":"N Engl J Med"},{"key":"BF6605490_CR31","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/jcp.21635","volume":"218","author":"MR Schneider","year":"2009","unstructured":"Schneider MR, Wolf E (2009) The epidermal growth factor receptor ligands at a glance. J Cell Physiol 218: 460\u2013466","journal-title":"J Cell Physiol"},{"key":"BF6605490_CR32","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1242\/dev.00664","volume":"130","author":"M Sibilia","year":"2003","unstructured":"Sibilia M, Wagner B, Hoebertz A, Elliott C, Marino S, Jochum W, Wagner EF (2003) Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heart. Development 130: 4515\u20134525","journal-title":"Development"},{"key":"BF6605490_CR33","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1172\/JCI112677","volume":"78","author":"N Takahashi","year":"1986","unstructured":"Takahashi N, MacDonald BR, Hon J, Winkler ME, Derynck R, Mundy GR, Roodman GD (1986) Recombinant human transforming growth factor-alpha stimulates the formation of osteoclast-like cells in long-term human marrow cultures. J Clin Invest 78: 894\u2013898","journal-title":"J Clin Invest"},{"key":"BF6605490_CR34","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1056\/NEJMoa030847","volume":"349","author":"E Tian","year":"2003","unstructured":"Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B, Shaughnessy Jr JD (2003) The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 349: 2483\u20132494","journal-title":"N Engl J Med"},{"key":"BF6605490_CR35","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10549-004-1720-2","volume":"89","author":"G von Minckwitz","year":"2005","unstructured":"von Minckwitz G, Jonat W, Fasching P, du Bois A, Kleeberg U, Luck HJ, Kettner E, Hilfrich J, Eiermann W, Torode J, Schneeweiss A (2005) A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer. Breast Cancer Res Treat 89: 165\u2013172","journal-title":"Breast Cancer Res Treat"},{"key":"BF6605490_CR36","doi-asserted-by":"publisher","first-page":"53848","DOI":"10.1074\/jbc.M403114200","volume":"279","author":"K Wang","year":"2004","unstructured":"Wang K, Yamamoto H, Chin JR, Werb Z, Vu TH (2004) Epidermal growth factor receptor-deficient mice have delayed primary endochondral ossification because of defective osteoclast recruitment. J Biol Chem 279: 53848\u201353856","journal-title":"J Biol Chem"},{"key":"BF6605490_CR37","first-page":"2940","volume":"63","author":"KL Weber","year":"2003","unstructured":"Weber KL, Doucet M, Price JE, Baker C, Kim SJ, Fidler IJ (2003) Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice. Cancer Res 63: 2940\u20132947","journal-title":"Cancer Res"},{"key":"BF6605490_CR38","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1007\/s00018-008-7440-8","volume":"65","author":"M Wieduwilt","year":"2008","unstructured":"Wieduwilt M, Moasser M (2008) The epidermal growth factor receptor family: biology driving targeted therapeutics. Cell Mol Life Sci 65: 1566\u20131584","journal-title":"Cell Mol Life Sci"},{"key":"BF6605490_CR39","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1083\/jcb.200307035","volume":"163","author":"S Yamazaki","year":"2003","unstructured":"Yamazaki S, Iwamoto R, Saeki K, Asakura M, Takashima S, Yamazaki A, Kimura R, Mizushima H, Moribe H, Higashiyama S, Endoh M, Kaneda Y, Takagi S, Itami S, Takeda N, Yamada G, Mekada E (2003) Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities. J Cell Biol 163: 469\u2013475, jcb.200307035","journal-title":"J Cell Biol"},{"key":"BF6605490_CR40","doi-asserted-by":"publisher","first-page":"26656","DOI":"10.1074\/jbc.M705064200","volume":"282","author":"J Zhu","year":"2007","unstructured":"Zhu J, Jia X, Xiao G, Kang Y, Partridge NC, Qin L (2007) EGF-like ligands stimulate osteoclastogenesis by regulating expression of osteoclast regulatory factors by osteoblasts. J Biol Chem 282: 26656\u201326664","journal-title":"J Biol Chem"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6605490.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605490","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6605490.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:43:28Z","timestamp":1684413808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6605490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,15]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["BF6605490"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6605490","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,15]]}}}